Skip to Content

ER 1 0.375 (Pramipexole Dihydrochloride Extended-Release 0.375 mg)

Pill with imprint ER 1 0.375 is White, Round and has been identified as Pramipexole dihydrochloride extended-release 0.375 mg. It is supplied by Macleods Pharmaceuticals Limited.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; tardive dyskinesia; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ER 1 0.375

Pramipexole dihydrochloride extended-release

ER 1 0.375
0.375 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.